Trimurthi [TRIMURTHI] vs Welcure Drugs [WELCURE] Detailed Stock Comparison

Trimurthi Ltd.

BSE
Loading...

Welcure Drugs & Pharmaceuticals Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Trimurthi Ltd. wins in 2 metrics, Welcure Drugs & Pharmaceuticals Ltd. wins in 7 metrics, with 2 ties. Welcure Drugs & Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Trimurthi Ltd. Welcure Drugs & Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 102.35 1.30 Welcure Drugs & Pharmaceuticals Ltd.
Price-to-Book Ratio N/A 0.28 N/A
Debt-to-Equity Ratio N/A 91.72 N/A
PEG Ratio -0.22 0.01 Welcure Drugs & Pharmaceuticals Ltd.
EV/EBITDA 0.00 2.81 Tie
Profit Margin (TTM) 3.73% 12.21% Welcure Drugs & Pharmaceuticals Ltd.
Operating Margin (TTM) 0.35% 12.24% Welcure Drugs & Pharmaceuticals Ltd.
EBITDA Margin (TTM) 0.35% 12.24% Welcure Drugs & Pharmaceuticals Ltd.
Return on Equity N/A 2.12% N/A
Return on Assets (TTM) 30.90% 0.81% Trimurthi Ltd.
Free Cash Flow (TTM) N/A $-2.22B N/A
1-Year Return 100.43% -72.38% Trimurthi Ltd.
Price-to-Sales Ratio (TTM) 1.63 0.10 Welcure Drugs & Pharmaceuticals Ltd.
Enterprise Value $0 $1.26B Welcure Drugs & Pharmaceuticals Ltd.
EV/Revenue Ratio 0.00 0.34 Tie
Gross Profit Margin (TTM) 5.24% N/A N/A
Revenue per Share (TTM) N/A $2 N/A
Earnings per Share (Diluted) N/A $0.23 N/A
Beta (Stock Volatility) N/A -1.80 N/A

Trimurthi Ltd. vs Welcure Drugs & Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

TRIMURTHI
WELCURE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Trimurthi Ltd.-3.89%-3.79%-5.23%-9.11%-21.39%-14.26%
Welcure Drugs & Pharmaceuticals Ltd.-3.70%-6.90%-3.57%-10.00%-52.63%-35.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Trimurthi Ltd.100.43%446.34%608.86%636.84%241.46%241.46%
Welcure Drugs & Pharmaceuticals Ltd.-72.38%-21.62%26.09%141.67%93.33%-45.28%

Performance & Financial Health Analysis: Trimurthi Ltd. vs Welcure Drugs & Pharmaceuticals Ltd.

MetricTRIMURTHIWELCURE
Market Information
Market Cap i₹500.39M₹370.78M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,83913,383,901
90 Day Avg. Volume i5,94010,165,552
Last Close₹52.67₹0.26
52 Week Range₹27.94 - ₹70.16₹0.23 - ₹1.44
% from 52W High-24.93%-82.00%
All-Time High₹70.16 (Nov 19, 2025)₹25.00 (Sep 19, 2005)
% from All-Time High-24.93%-98.96%
Growth Metrics
Quarterly Revenue Growth0.34%-1.00%
Quarterly Earnings Growth9.63%1.57%
Financial Health
Profit Margin (TTM) i0.04%0.12%
Operating Margin (TTM) i0.00%0.12%
Return on Equity (TTM) iN/A0.02%
Debt to Equity (MRQ) iN/A91.72
Cash & Liquidity
Book Value per Share (MRQ)N/A₹1.09
Cash per Share (MRQ)N/A₹0.02
Operating Cash Flow (TTM) i₹-159,000₹-2,249,340,000
Levered Free Cash Flow (TTM) i₹845,000₹21.70M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Trimurthi Ltd. vs Welcure Drugs & Pharmaceuticals Ltd.

MetricTRIMURTHI (Apr 08, 2026)WELCURE (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i102.351.30
Forward P/E iN/AN/A
PEG Ratio i-0.220.01
Price to Sales (TTM) i1.630.10
Price to Book (MRQ) iN/A0.28
Market Capitalization
Market Capitalization i₹500.39M₹370.78M
Enterprise Value i₹0₹1.26B
Enterprise Value Metrics
Enterprise to Revenue i0.000.34
Enterprise to EBITDA i0.002.81
Risk & Other Metrics
Beta iN/A-1.80
Book Value per Share (MRQ) iN/A₹1.09

Financial Statements Comparison: Trimurthi Ltd. vs Welcure Drugs & Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTRIMURTHI (2025)WELCURE (2025)
Revenue/Sales i307.19M245.50M
Cost of Goods Sold i295.74M205.03M
COGS % of Revenue i96.3%83.5%
Gross Profit i11.45M40.47M
Gross Margin i3.7%16.5%
Research & Development iN/AN/A
Operating Income (EBIT) i1.07M9.61M
Operating Margin i0.3%3.9%
EBITDA i1.45M-9.41M
EBITDA Margin i0.5%-3.8%
Pre-Tax Income i1.23M27.80M
Pre-Tax Income % of Revenue i0.4%11.3%
Income Tax i388,0006.10M
Income Tax % of Revenue i0.1%2.5%
Net Income (Profit) i845,00021.70M
Profit Margin i0.3%8.8%

Balance Sheet & Liquidity Metrics

MetricTRIMURTHI (2025)WELCURE (2025)
Cash & Equivalents iN/A1.28M
Total Current Assets iN/A1.82B
Total Current Assets % of Revenue i0.0%741.9%
Total Current Liabilities iN/A412.69M
Total Current Liabilities % of Revenue i0.0%168.1%
Long-Term Debt i01.23B
Long-Term Debt % of Revenue i0.0%501.8%
Total Shareholders Equity iN/A1.03B
Retained Earnings iN/A-100.79M
Retained Earnings % of Revenue i0.0%-41.1%
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison

MetricTRIMURTHI (2025)WELCURE (2025)
Operating Cash Flow i-159,000-2.25B
Operating Cash Flow % of Revenue i-0.1%-916.2%
Capital Expenditures iN/A-170,000
Free Cash Flow iN/A-2.22B
FCF Margin i0.0%-904.5%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTRIMURTHIWELCURE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.95M1.24B
Float Shares iN/A6.63M
% Held by Insiders iN/A85.74%
% Held by Institutions iN/A0.00%
% Held by Public iN/A14.26%

Dividend Analysis & Yield Comparison: Trimurthi Ltd. vs Welcure Drugs & Pharmaceuticals Ltd.

MetricTRIMURTHIWELCURE
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A